Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Alkylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Patent CN101735201B details a high-yield Piribedil synthesis via Blanc chloromethylation and mild N-alkylation, offering cost-effective API intermediate manufacturing solutions.
Patent CN111138315B reveals a scalable Ag-catalyzed route for cyanoalkyl quinones, replacing costly photocatalysis for efficient pharmaceutical intermediate manufacturing.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Patent CN107089940B enables efficient meta-alkylation. This technology reduces production costs and improves supply chain reliability for high-purity pharmaceutical intermediates globally.
Novel one-pot method for econazole nitrate reduces steps and cost. Reliable supply chain for high-purity API manufacturing with enhanced efficiency and green chemistry.
Novel iodine-catalyzed method for C3-alkylated indoles offers metal-free green synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Novel iridium-catalyzed N-alkylation method for 2-(N-alkyl)aminopyrimidines using alcohols. High atom economy, water byproduct only. Ideal for pharma intermediates.
Efficient bromination and decarboxylation route for high-purity pyrrole acid anhydrides. Reduces steps and improves yield for reliable supply chain.
Patent CN110467613B reveals a mild nickel-catalyzed route for isoindolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102627573B details a high-yield synthesis of 5-aminolevulinic acid hydrochloride using 1,3-dichloroacetone, offering cost reduction and supply chain stability.
Patent CN112125843B reveals a green Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN104250254B offers a rapid method for hexahydropyrroloindole derivatives with 85% yield. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Patent CN110105319A details iron-catalyzed C-3 alkylation. Offers green, scalable route for pharmaceutical intermediates with cost advantages.
Patent CN112125843B reveals a metal-free Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel patent CN120698921A enables noble-metal-free synthesis. Reduces cost and safety risks for pharmaceutical intermediate manufacturing supply chains.
Novel base-free alkylation process for Indacaterol Maleate achieving 93% yield. Reduces regioisomers and ensures supply chain stability for respiratory API manufacturing.
Patent CN111116465B reveals Ag-catalyzed cyanoalkylation. Efficient route for drug intermediates with scalable conditions.
Overcome moisture sensitivity and noble metal dependency in pyrimidine synthesis. Achieve 50-86% yields with simplified 3-step process for stable API supply chains.